Clinical Trials in Los Angeles

Showing 7901-7920 of 16,901 trials

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

NCT03970382

This is a first in human, single arm, open label, Phase 1a/1b study to determine the safety, feasibility, and efficacy of a single dose of NeoTCR-P1 T cells in participants with solid tumors.

Solid Tumor

PACT Pharma, Inc.21 participantsStarted Jul 2019

Duarte, California, United States • Los Angeles, California, United States • Orange, California, United States +6 more locations

COMPLETEDPhase 3< 1 mile

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

NCT03813160

This is a Phase 3 multicenter, double-blind, randomized, placebo-controlled study assessing the efficacy and safety of lenabasum for the treatment of dermatomyositis. Approximately 150 subjects will be enrolled in this study at about 60 sites in North America, Europe, and Asia. The planned duration of double-blind treatment with study drug is up to 52 weeks.

Dermatomyositis

Corbus Pharmaceuticals Inc.176 participantsStarted Dec 2018

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Beverly Hills, California, United States +51 more locations

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

Find Trials by Condition in Los Angeles

A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies

TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients

A Study of LY3561774 in Participants With Dyslipidemia

Promoting the Use of CPAP Therapy Among OSA Patients

Study Evaluating Techniques for Measuring Tear Production

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)